UTHR: Aggressive product launches and innovation aim for $50–100B revenue and industry leadership
Category: Business
Share
Archive
Like
Fourteen new products are set for rapid launch, targeting $50–100 billion in annual pharma revenue and addressing a million-patient market. Key innovations include once-daily and coughless inhalers, with strong IP protection and major investments in manufacturing and xenotransplantation.
Based on United Therapeutics Corporation [UTHR] Wells Fargo 21st Annual Healthcare Conference Audio Transcript — Sep. 8 2026
A note on cookies
Newshunt uses essential cookies to keep you signed in and to remember your language and country, so the site works the way you expect. With your permission, we'd also like to use analytics cookies to understand how people use Newshunt and improve it over time.
Accepting only affects analytics. To learn more, view our Privacy Policy or Terms & Conditions.
(0)Comments